| Periphon D Faustino, PT | |
|
375 Mccarter Hwy, Newark, NJ 07114 | |
| (973) 643-8601 | |
| (973) 643-8609 |
| Full Name | Periphon D Faustino |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 375 Mccarter Hwy, Newark, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083732796 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT6503 (Florida) | Secondary |
| 225100000X | Physical Therapist | 40QA00810200 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Periphon D Faustino, PT 375 Mccarter Hwy, Newark, NJ 07114-2562 Ph: (973) 643-8601 | Periphon D Faustino, PT 375 Mccarter Hwy, Newark, NJ 07114 Ph: (973) 643-8601 |
News Archive
Canada's nurses will play a lead role in ensuring a dynamic, publicly funded health-care system for all Canadians, according to the National Expert Commission's (NEC) Report released to the public today at the Canadian Nurses Association (CNA) biennial convention in Vancouver.
Given that 10.5 % of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the design of a tool capable of preventing this problem.
Researchers are calling for a randomized clinical trial to investigate the potential role of vitamin D supplementation in improving live birth rates following assisted reproduction treatment.
Cellular Dynamics International, Inc. (CDI), the world's largest producer of cellular tools for drug discovery and safety derived from induced pluripotent stem cells (iPSCs), and iPS Academia Japan, Inc., today announced a nonexclusive licensing agreement for the seminal iPSC patent portfolio arising out of the work of Dr. Shinya Yamanaka, M.D., Ph.D., Center for iPS Cell Research and Application (CiRA), Kyoto University.
The U.S. Food and Drug Administration today approved Voraxaze (glucarpidase) to treat patients with toxic levels of methotrexate in their blood due to kidney failure.
› Verified 2 days ago
Total Care Physical Therapy Center, Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 119-137 Clifford St, L-3a, Newark, NJ 07105 Phone: 973-648-6808 Fax: 973-642-3516 | |
Ms. Marcia Claudette Downer, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Pm&r B403, University Hospital, 150 Bergen Street, Newark, NJ 07103 Phone: 973-972-7188 Fax: 973-972-5725 | |
Peak Performance Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 250 Mcwhorter St, Newark, NJ 07105 Phone: 973-344-0012 Fax: 973-344-0898 | |
Anthony Santigate, THERAPY DIR II Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 560 Broad St, Newark, NJ 07102 Phone: 973-643-4969 Fax: 973-643-4573 | |
Mrs. Antonia O Christian-thompson, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 65 Bergen St, Newark, NJ 07107 Phone: 973-972-0186 | |
Ms. Laura N Phillips, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 65 Bergen Street, Room 601, Newark, NJ 07101 Phone: 973-972-9628 | |
Dr. Magdalena Karasewicz, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 65 Bergen St, Newark, NJ 07107 Phone: 973-973-0186 Fax: 973-972-2645 |